Volume 58, Issue 11 pp. 3300-3345
Review

A Structural View on Medicinal Chemistry Strategies against Drug Resistance

Dr. Stefano Agnello

Dr. Stefano Agnello

Institute of Chemistry and Biotechnology, Center for Organic and Medicinal Chemistry, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland

These authors contributed equally to this work.

Search for more papers by this author
Dr. Michael Brand

Dr. Michael Brand

Institute of Chemistry and Biotechnology, Center for Organic and Medicinal Chemistry, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland

These authors contributed equally to this work.

Search for more papers by this author
Dr. Mathieu F. Chellat

Dr. Mathieu F. Chellat

Institute of Chemistry and Biotechnology, Center for Organic and Medicinal Chemistry, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland

These authors contributed equally to this work.

Search for more papers by this author
Dr. Silvia Gazzola

Dr. Silvia Gazzola

Institute of Chemistry and Biotechnology, Center for Organic and Medicinal Chemistry, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland

These authors contributed equally to this work.

Search for more papers by this author
Prof. Dr. Rainer Riedl

Corresponding Author

Prof. Dr. Rainer Riedl

Institute of Chemistry and Biotechnology, Center for Organic and Medicinal Chemistry, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 31, 8820 Wädenswil, Switzerland

Search for more papers by this author
First published: 30 May 2018
Citations: 53

Graphical Abstract

Resistance is futile: The emergence of drug resistance has far-reaching consequences for clinical efficacy. This Review presents an analysis of the underlying structural mechanisms of drug resistance across different therapeutic indications and highlights rational approaches to overcome this threat to public health.

Abstract

The natural phenomenon of drug resistance is a widespread issue that hampers the performance of drugs in many major clinical indications. Antibacterial and antifungal drugs are affected, as well as compounds for the treatment of cancer, viral infections, or parasitic diseases. Despite the very diverse set of biological targets and organisms involved in the development of drug resistance, the underlying molecular mechanisms have been identified to understand the emergence of resistance and to overcome this detrimental process. Detailed structural information on the root causes for drug resistance is nowadays frequently available, so next-generation drugs can be designed that are anticipated to suffer less from resistance. This knowledge-based approach is essential for fighting the inevitable occurrence of drug resistance.

Conflict of interest

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.